NY-TOPPAN-MERRILL
Toppan Merrill , a subsidiary of Toppan Leefung Pte. Ltd . and part of Toppan Inc. , the world's leading printing group, announced JoAnn Kern as the company’s president.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210715005065/en/
Jeffrey Riback, who has served as President since 2012, has retired. Riback will retain a position on the Toppan Merrill board.
“JoAnn Kern is an energetic entrepreneur and global business leader. She possesses the expertise and passion to lead Toppan Merrill’s mission to Expand Possible through expert-enabled technology for our clients,” said Riback.
Kern feels this is a tremendous opportunity to continue the momentum of Toppan Merrill’s 50+ year legacy of delivering premier, technology-driven solutions to communicate mission-critical content more efficiently and accurately.
“What matters most is for Toppan Merrill to strive to exceed our clients' expectations and help them achieve their goals. My vision is to power a global brand by delivering forward-thinking technology innovation coupled with renowned industry expertise,” said Kern.
Kern, who will assume the president role immediately, started at Toppan Merrill over 20 years ago and most recently held the role of Chief Financial Officer. Toppan Merrill plans to hire a new Chief Financial Officer to replace Kern.
About Toppan Merrill
Toppan Merrill, a leader in financial printing and communication solutions, is part of Toppan Inc., a diversified global leader in solutions for printing, communications, security, packaging, décor materials, electronics, and digital transformation, headquartered in Tokyo, with approximately US$14 billion in annual sales. Toppan Merrill has been a pioneer and trusted partner to the financial, legal and corporate communities for five decades, providing secure, innovative solutions to complex content and communications requirements. Through proactive partnerships, unparalleled expertise, continuous innovation and unmatched service, Toppan Merrill delivers a hassle-free experience for mission-critical content for capital markets transactions, financial reporting and regulatory disclosure filings, and marketing and communications solutions for regulated and non-regulated industries.
With global expertise in major capital markets, Toppan Merrill delivers unmatched service around the world.
Learn more at www.toppanmerrill.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210715005065/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Perma-Pipe International Holdings, Inc. Secures $52 Million in Third-Quarter Awards, Expands Global Reach With U.S. Data Centers and Saudi Aramco Projects3.12.2025 14:45:00 CET | Press release
Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) today announced that it secured $52 million in project awards during the third quarter of 2025, including $30 million previously announced in September. The additional $22 million in new awards includes major data center infrastructure projects in the United States and Saudi Aramco–related projects to be executed from the company’s recently approved Dammam, Saudi Arabia facility. “These awards underscore the accelerating demand we’re seeing across mission-critical infrastructure, especially in the data center sector,” said Marc Huber, Senior Vice President, North America. “Our teams continue to deliver the technical capabilities, responsiveness, and reliability that our customers expect as they scale up.” Adham Sharkawi, Senior Vice President, MENA, added: “Growth in the Kingdom of Saudi Arabia is a strategic priority for Perma-Pipe. The new Saudi Aramco awards demonstrate our strengthened local presence in Dammam and reinforce our
Second Front Systems Announces 10 Customers Prepared to Deploy on AWS European Sovereign Cloud via Game Warden® Platform3.12.2025 14:30:00 CET | Press release
Unlocks opportunity for Second Front customers to support European nations with strict data sovereignty requirements. Second Front Systems (2F), a Technology Partner in the Amazon Web Services (AWS) Partner Network (APN) and Global Security and Compliance Acceleration (GSCA) Program, today announced that ten of its existing customers have prepared for deployment onto AWS European Sovereign Cloud (ESC) via its 2F Game Warden® platform. This builds on Second Front's September announcement that 2F Game Warden will serve as an on-ramp to ESC. Independent software vendors (ISVs) seeking to support European organizations face complex regulatory requirements, including Germany's C5, and the EU's Digital Operational Resilience Act (DORA) and NIS2 Directive. By leveraging 2F Game Warden, ISVs can inherit a number of controls and expedite compliance with security frameworks. This collaboration unlocks a pre-validated solution for ISVs to meet these stringent compliance requirements while maintai
ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma3.12.2025 14:00:00 CET | Press release
Prospective, randomized controlled trial compares novel femtosecond laser procedure to selective laser trabeculoplasty (SLT), advancing path to US commercialization ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S. Investigational Device Exemption (IDE) clinical trial evaluating the company’s femtosecond laser trabeculotomy procedure for the management of glaucoma, a lifelong, progressive, and incurable disease that remains a leading cause of irreversible blindness worldwide. This prospective, multicenter, randomized, controlled trial evaluates the ViaLase procedure in comparison to selective laser trabeculoplasty (SLT), the current standard laser treatment for reducing intraocular pressure (IOP). This trial was designed in consultation with the FDA to achieve clearance and commercialization in the U.S. and thus represents one of the most rigorous e
Winchester Interconnect Launches LiteSPEed™ Cable: Faster, Lighter, Simpler Connectivity for Mission-Critical Systems3.12.2025 14:00:00 CET | Press release
Winchester Interconnect, an Aptiv company and leading supplier of high-performance interconnect solutions, today introduced LiteSPEed™ Cable, a next-generation single-pair Ethernet (SPE) solution that delivers 10-gigabit data rates in a dramatically smaller, lighter design. Built for the increasingly connected and space-constrained environments of aerospace, defense, industrial automation and next-generation mobility, LiteSPEed™ helps customers move more data with less cable, reducing weight, complexity, and cost while increasing system performance and reliability. “As systems become more intelligent and interconnected, engineers need lighter, more efficient ways to deliver power and data,” said Juan Contreres, director of product management. “LiteSPEed™ gives them a rugged, high-speed Ethernet solution that simplifies installation without compromising performance.” With advanced sensors, real-time analytics, and distributed control systems proliferating across industries, cabling has
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides3.12.2025 14:00:00 CET | Press release
Owkin shares promising validation results for BRCAura RUO, a clinical-grade research-use-only AI product designed to screen for germline BRCA1/2 mutations (gBRCAm) directly from digitized breast cancer pathology slides. Breast cancer remains the leading cause of cancer-related deaths among women worldwide. Identifying patients with germline BRCA1/2 mutations is essential for guiding targeted treatment decisions, but testing is not always consistently offered to eligible individuals, and implementation varies between countries. The model concept was initiated as part of Owkin’s ongoing partnership with Gustave Roussy and Centre Léon Bérard through PortrAIt, a French consortium dedicated to advancing precision medicine with AI-enabled digital pathology. Fostered through collaboration with AstraZeneca, as announced in October 2024, the development of BRCAura aims to accelerate and expand identification of BRCA mutations in patients with breast cancer. Strong validation across internationa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom